Literature DB >> 21493511

Diagnosis and economic consequences of triclabendazole resistance in Fasciola hepatica in a sheep flock in south-east Scotland.

N D Sargison1, P R Scott.   

Abstract

Over the past decade, definite changes have been recorded in the regional prevalence, seasonality and severity of fasciolosis in the UK, related to increased rainfall, or localised flooding, prompting debate about the deleterious effects of climate change. As a consequence, effective management of fasciolosis has become problematic in areas where fluke traditionally exists, leading to serious loss of production in sheep and cattle. Meanwhile, in eastern districts, there have been unexpected outbreaks of disease, resulting in production losses and concerns about welfare. This case report describes the economic consequences of fasciolosis in a commercial sheep flock in south-east Scotland. The diagnosis and consequences of triclabendazole resistance are discussed, in the context of developing economically sustainable control strategies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21493511     DOI: 10.1136/vr.c5332

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  16 in total

1.  Identification and expression of a transforming growth factor beta (TGF-β) homologue in the tropical liver fluke Fasciola gigantica.

Authors:  Ornampai Japa; Khanuengnij Prakhammin; Robin J Flynn
Journal:  Parasitol Res       Date:  2022-10-04       Impact factor: 2.383

Review 2.  Fasciolosis-An Increasing Challenge in the Sheep Industry.

Authors:  Snorre Stuen; Cecilie Ersdal
Journal:  Animals (Basel)       Date:  2022-06-08       Impact factor: 3.231

3.  Epidemiology and impact of Fasciola hepatica exposure in high-yielding dairy herds.

Authors:  Alison Howell; Matthew Baylis; Rob Smith; Gina Pinchbeck; Diana Williams
Journal:  Prev Vet Med       Date:  2015-06-05       Impact factor: 2.670

4.  Estimation of the impact of Fasciola hepatica infection on time taken for UK beef cattle to reach slaughter weight.

Authors:  Stella Mazeri; Gustaf Rydevik; Ian Handel; Barend M deC Bronsvoort; Neil Sargison
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

5.  Combining Slaughterhouse Surveillance Data with Cattle Tracing Scheme and Environmental Data to Quantify Environmental Risk Factors for Liver Fluke in Cattle.

Authors:  Giles T Innocent; Lucy Gilbert; Edward O Jones; James E McLeod; George Gunn; Iain J McKendrick; Steve D Albon
Journal:  Front Vet Sci       Date:  2017-05-08

6.  Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle.

Authors:  Yvette M Brockwell; Timothy P Elliott; Glenn R Anderson; Rex Stanton; Terry W Spithill; Nicholas C Sangster
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-12-11       Impact factor: 4.077

7.  Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series.

Authors:  Miguel M Cabada; Martha Lopez; Maria Cruz; Jennifer R Delgado; Virginia Hill; A Clinton White
Journal:  PLoS Negl Trop Dis       Date:  2016-01-25

8.  Evaluation of the Performance of Five Diagnostic Tests for Fasciola hepatica Infection in Naturally Infected Cattle Using a Bayesian No Gold Standard Approach.

Authors:  Stella Mazeri; Neil Sargison; Robert F Kelly; Barend M deC Bronsvoort; Ian Handel
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

9.  Development and validation of a protocol to identify and recruit participants into a large scale study on liver fluke in cattle.

Authors:  Catherine M McCann; Helen E Clough; Matthew Baylis; Diana J L Williams
Journal:  BMC Vet Res       Date:  2018-06-15       Impact factor: 2.741

Review 10.  Fasciola and fasciolosis in ruminants in Europe: Identifying research needs.

Authors:  N J Beesley; C Caminade; J Charlier; R J Flynn; J E Hodgkinson; A Martinez-Moreno; M Martinez-Valladares; J Perez; L Rinaldi; D J L Williams
Journal:  Transbound Emerg Dis       Date:  2017-10-06       Impact factor: 5.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.